Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EPS (Basic): 2020-2025

Historic EPS (Basic) for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to -$0.17.

  • Roivant Sciences' EPS (Basic) rose 45.16% to -$0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.58, marking a year-over-year decrease of 109.90%. This contributed to the annual value of -$0.75 for FY2025, which is 112.61% down from last year.
  • As of Q3 2025, Roivant Sciences' EPS (Basic) stood at -$0.17, which was up 48.48% from -$0.33 recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' EPS (Basic) peaked at $6.44 during Q4 2023, and registered a low of -$0.49 during Q4 2022.
  • For the 3-year period, Roivant Sciences' EPS (Basic) averaged around $0.65, with its median value being -$0.24 (2025).
  • In the last 5 years, Roivant Sciences' EPS (Basic) slumped by 550.00% in 2021 and then surged by 1,414.29% in 2023.
  • Quarterly analysis of 5 years shows Roivant Sciences' EPS (Basic) stood at -$0.41 in 2021, then dropped by 19.51% to -$0.49 in 2022, then surged by 1,414.29% to $6.44 in 2023, then tumbled by 96.43% to $0.23 in 2024, then surged by 45.16% to -$0.17 in 2025.
  • Its EPS (Basic) was -$0.17 in Q3 2025, compared to -$0.33 in Q2 2025 and $0.23 in Q4 2024.